通过调节集体细胞-细胞行为,稳定和高效地生成功能性iPSC衍生的神经前代细胞
Mee-Hae Kim1, Naruchit Thanuthanakhun1, Masahiro Kino-Oka1,2
1Department of Biotechnology, Graduate School of Engineering, Osaka University, Osaka, Japan.
Frontiers in bioengineering and biotechnology
|January 25, 2024
概括
玻尿酸血凝素 (HA) 增强神经原生细胞从诱导多能干细胞 (iPSCs) 产生红. 这种新的方法提高了再生医学应用的差异化效率和可重复性.
科学领域:
- 干细胞生物学 干细胞生物学
- 再生医学是一种再生医学.
- 神经科学是一个神经科学.
背景情况:
- 诱导多能干细胞 (iPSCs) 对再生医学具有前景.
- 低的分化效率和可重复性阻碍了干细胞的临床应用.
研究的目的:
- 开发一种有效的策略,用于从iPSCs生成神经原生细胞红.
- 为了提高神经原始细胞衍生的效率和稳定性.
主要方法:
- 利用肉血素 (HA) 抑制iPSCs的自发分化.
- 在神经前体分化过程中,结合双重SMAD抑制的HA治疗.
- 在特定的差异化条件下培养iPSC,以促进罗塞特的形成.
主要成果:
- 治疗HA保留了多能性,并抑制了自发分化.
- 与对照人群相比,获得神经前代细胞产量高出8.4倍.
- 产生了PAX6和SOX1表达神经前代细胞的同质群体.
- 神经前代细胞形成了带有中心光线的辐射组织的粉丝圈.
结论:
- 肉血凝素 (HA) 在抑制自发分化和促进空间均性方面具有重要意义.
- 在神经前代细胞的形状的形成和成熟中,HA在形态遗传学上起着重要的作用.
- 这种新的方法有效地获得了功能性iPSC衍生的神经原生细胞罗塞特,用于潜在的治疗用途.
更多相关视频
14:192D and 3D Human Induced Pluripotent Stem Cell-Based Models to Dissect Primary Cilium Involvement during Neocortical Development
Published on: March 25, 2022
3.9K
11:52Establishment of an Electrophysiological Platform for Modeling ALS with Regionally-Specific Human Pluripotent Stem Cell-Derived Astrocytes and Neurons
Published on: August 26, 2021
2.3K
相关概念视频
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
